Education
About Us
Working with TipRanks
Follow Us
NeonMind Biosciences Inc (TSE:LCR)
:LCR
LCR Stock Chart & Stats
C$0.04
C$0.00(0.00%)
At close: 4:00 PM EST
C$0.04
C$0.00(0.00%)
Day’s Range― - ―
52-Week RangeC$0.01 - C$0.08
Previous CloseN/A
Volume126.00K
Average Volume (3M)290.69K
Market Cap
C$4.16M
Enterprise ValueC$3.64M
Total Cash (Recent Filing)C$206.03K
Total Debt (Recent Filing)C$1.14M
Price to Earnings (P/E)―
Beta0.19
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding92,499,870
10 Day Avg. Volume583,757
30 Day Avg. Volume290,695
Financial Highlights & Ratios
PEG Ratio0.45
Price to Book (P/B)-9.40
Price to Sales (P/S)0.00
P/FCF Ratio-6.04
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Improving Cash BurnA material improvement in operating cash flow versus the prior year indicates management has started to rein in spending or improve operational efficiency. Over a multi-month horizon this reduces immediate financing pressure, lengthens runway, and preserves strategic optionality for R&D or commercialization steps.
Smaller Historical Losses Vs Prior PeakA reduction from prior peak losses suggests progress on cost control or program prioritization. This structural improvement, if sustained, improves survivability between financing rounds and supports a clearer path to investing resources into revenue-generating activities when development milestones are met.
Lean Operating HeadcountA small, lean workforce indicates lower fixed overhead and greater operating flexibility for a pre-revenue company. Sustaining a compact team limits cash outflows, helps extend runway, and allows focused deployment of limited capital toward high-impact R&D or commercialization tasks over several months.
Bears Say
Pre-revenue With Persistent LossesBeing pre-revenue and consistently loss-making means the business lacks an internal source of financing from operations. Over the medium term this constrains the firm's ability to scale, forces reliance on external capital, and increases execution risk if financing markets tighten or milestone delivery slips.
Negative Shareholders' EquityNegative equity reflects prolonged losses that have eroded capital and raises solvency concerns. Structurally this limits borrowing capacity, can increase financing costs, and often leads to dilution through equity raises—reducing long-term financial flexibility and investor optionality.
Consistent Negative Operating And Free Cash FlowSustained negative operating and free cash flow means the company cannot self-fund operations or growth. Over a 2–6 month horizon this creates a structural dependence on external financing to maintain programs, increasing execution risk and potential for disruptive capital raises or program cutbacks.
NeonMind Biosciences Inc News
LCR FAQ
What was NeonMind Biosciences Inc’s price range in the past 12 months?
NeonMind Biosciences Inc lowest stock price was C$0.01 and its highest was C$0.08 in the past 12 months.
What is NeonMind Biosciences Inc’s market cap?
NeonMind Biosciences Inc’s market cap is C$4.16M.
When is NeonMind Biosciences Inc’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were NeonMind Biosciences Inc’s earnings last quarter?
Currently, no data Available
Is NeonMind Biosciences Inc overvalued?
According to Wall Street analysts NeonMind Biosciences Inc’s price is currently Overvalued.
Does NeonMind Biosciences Inc pay dividends?
NeonMind Biosciences Inc does not currently pay dividends.
What is NeonMind Biosciences Inc’s EPS estimate?
NeonMind Biosciences Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does NeonMind Biosciences Inc have?
NeonMind Biosciences Inc has 92,499,870 shares outstanding.
What happened to NeonMind Biosciences Inc’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of NeonMind Biosciences Inc?
Currently, no hedge funds are holding shares in TSE:LCR
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
NeonMind Biosciences Inc
Lancaster Resources Inc. engages in the acquisition, exploration, and development of mineral properties and renewable energy projects. It has option to acquire a 100% interest in the Alkali Flat lithium brine project situated in Lordsburg, New Mexico, the United States. The company is based in West Vancouver, Canada.
Technical Analysis
Options Prices
Currently, No data available
---